跳至主要内容
临床试验/NL-OMON54123
NL-OMON54123尚未招募3 期

COLLISION RELAPSE trial - Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvant systemic therapy - a phase III prospective randomized controlled trial - COLLISION RELAPSE - Repeat local treatment +/- neoadjuvant systemic therapy

Vrije Universiteit Medisch Centrum0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Histological documentation of primary colorectal tumor
  • - Local treatment performed for initial CRLM
  • - >=1 locally treatable recurrent CRLM (partial hepatectomy and/or thermal
  • - Resection for resectable lesions considered possible obtaining negative
  • resection margins (R0) and preserving adequate liver reserve
  • - Total number of new CRLM <= 5
  • - No microsatellite instability (MSI)
  • - Good performance status (ECOG 0-2) // ASA 1-3
  • - No extrahepatic disease
  • - Both chemo-naïve patients and patients who did not progress on either CAPOX,
  • FOLFOX, or FOLFIRI chemotherapy prior to the initial local treatment

排除标准

  • - Pregnant or breast-feeding subjects. Women of childbearing potential must
  • have a negative pregnancy test performed within 7 days of the start of
  • - Immunotherapy <= 6 weeks prior to the randomization;
  • - Chemotherapy <= 6 weeks prior to the randomization;
  • - Progression on both oxaliplatin and irinotecan;
  • - Severe allergy to contrast media not controlled with premedication.

研究者

相似试验